Using an animal model and a cell model overexpressing tau, purpurin was also able to alleviate Alzheimer’s disease (AD)-like symptoms and reduce the accumulation of total tau, respectively. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.